Dyadic Receives $3 Million Grant to Develop Cost-Effective Monoclonal Antibodies for RSV and Malaria Using C1 Platform Technology
November 21, 2024 08:30 ET
|
Dyadic International, Inc.
JUPITER, Fla., Nov. 21, 2024 (GLOBE NEWSWIRE) -- Dyadic International, Inc. (NASDAQ: DYAI), a global biotechnology company, announced today that it has been awarded a $3 million grant from the Gates...
Pacific Genetech Hercules Delivery System Recognized With “Vaccine Innovation Of The Year” By BioTech Breakthrough
November 19, 2024 08:01 ET
|
BioTech Breakthrough
FAYETTEVILLE, Ark., Nov. 19, 2024 (GLOBE NEWSWIRE) -- Pacific Genetech today announced that Hercules is the recipient of the “Vaccine Innovation Of The Year” award in the fourth annual BioTech...
Global Veterinary Vaccine Adjuvants Market to Reach USD 674.2 Million by 2034, Driven by Rising Demand for Animal Health Solutions | FMI
November 18, 2024 11:30 ET
|
Future Market Insights Global and Consulting Pvt. Ltd.
NEWARK, Del, Nov. 18, 2024 (GLOBE NEWSWIRE) -- The global veterinary vaccine adjuvants market is experiencing strong growth, with sales estimated to reach USD 431.4 million in 2024 and projected to...
Evaxion announces positive preclinical data for cytomegalovirus (CMV) vaccine program EVX-V1
November 12, 2024 08:00 ET
|
Evaxion Biotech
New preclinical data demonstrates that CMV antigens identified with Evaxion’s AI-Immunology™ platform trigger targeted immune responses Results also showcase the successful design of a proprietary...
HilleVax Reports Third Quarter 2024 Financial Results and Highlights Recent Company Progress
November 07, 2024 08:00 ET
|
HilleVax, Inc.
$189.3 million of cash, cash equivalents and marketable securities as of September 30, 2024 The company is exploring the potential for continued development of its norovirus vaccine candidates in...
Sabin Sends More Marburg Vaccines for Rwanda’s Outbreak
October 31, 2024 14:22 ET
|
Sabin Vaccine Institute
Photo caption: Rwanda Minister of State for Health, Yvan Butera, was among those who received Sabin’s investigational vaccine in the open-label clinical trial. WASHINGTON, Oct. 31, 2024 (GLOBE...
Curevo Presents Positive Shingles Vaccine Outcomes Data
October 31, 2024 02:00 ET
|
Curevo Vaccine
Zero shingles cases after 18.8 months follow-up in 619 patients receiving any dose of amezosvatein, a development-stage adjuvanted subunit vaccine
Curevo Vaccine Presents Amezosvatein Shingles Vaccine Data at ID Week
October 16, 2024 11:00 ET
|
Curevo Vaccine
Positive data from 876-patient head-to-head trial versus Shingrix® shows amezosvatein elicits robust immune responses with better tolerability.
Global Vaccine Market Size Expected to Reach USD 186.5 Billion by 2032 with 10.7% CAGR - SNS Insider
October 07, 2024 09:10 ET
|
SNS Insider pvt ltd
Pune, Oct. 07, 2024 (GLOBE NEWSWIRE) -- Vaccine Market Size & Growth Analysis: According to SNS Insider, The Vaccine Market Size was valued at USD 74.7 billion in 2023 and is expected to...
Sabin Vaccine Institute Delivers Marburg Vaccines to Combat Outbreak in Rwanda
October 05, 2024 18:24 ET
|
Sabin Vaccine Institute
[Caption] Sabin Vaccine Institute delivered 700 doses of its Marburg vaccine to Rwanda on Oct. 5, 2024. WASHINGTON, Oct. 05, 2024 (GLOBE NEWSWIRE) -- The Sabin Vaccine Institute has provided...